FINISHED DOSAGE FORMULATIONS
Drug : DELZICOL
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 204412
Country : US
Patented : No
Drug : ASACOL HD
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 21830
Country : US
Patented : No
Drug : URSO 250
Dosage Form : TABLET; ORAL
Application Number : 20675
Country : US
Patented : No
Drug : URSO FORTE
Dosage Form : TABLET; ORAL
Application Number : 20675
Country : US
Patented : No
Drug : OMEPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 203481
Country : US
Patented : No
Drug : OMEPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 75876
Country : US
Patented : No
Drug : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 205673
Country : US
Patented : No
Drug : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 205077
Country : US
Patented : No
Drug : TRAMADOL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78783
Country : US
Patented : No
Drug : TRAMADOL HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 76003
Country : US
Patented : No
DIBUTYL SEBACATE
Route : ORAL
CAS : 109-43-3
UNII : 4W5IH7FLNY
Potency Amount : 2.21
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DIBUTYL SEBACATE
Route : ORAL
CAS : 109-43-3
UNII : 4W5IH7FLNY
Potency Amount : 6.41
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DIBUTYL SEBACATE
Route : ORAL
CAS : 109-43-3
UNII : 4W5IH7FLNY
Potency Amount : 3.02
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DIBUTYL SEBACATE
Route : ORAL
CAS : 109-43-3
UNII : 4W5IH7FLNY
Potency Amount : 0.89
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DIBUTYL SEBACATE
Route : ORAL
CAS : 109-43-3
UNII : 4W5IH7FLNY
Potency Amount : 10
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DIBUTYL SEBACATE
Route : ORAL
CAS : 109-43-3
UNII : 4W5IH7FLNY
Potency Amount : 3.83
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DIBUTYL SEBACATE
Route : ORAL
CAS : 109-43-3
UNII : 4W5IH7FLNY
Potency Amount : 8.82
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DIBUTYL SEBACATE
Route : ORAL
CAS : 109-43-3
UNII : 4W5IH7FLNY
Potency Amount : 2.83
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DIBUTYL SEBACATE
Route : ORAL
CAS : 109-43-3
UNII : 4W5IH7FLNY
Potency Amount : 43.2
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DIBUTYL SEBACATE
Route : ORAL
CAS : 109-43-3
UNII : 4W5IH7FLNY
Potency Amount : 6
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
Application : Coating Systems & Additives
Excipient Details : Controlled-release coatings for tablets & capsules.
MARKET PLACE
Reply
24 Jan 2019
Reply
31 Mar 2025
Reply
16 Nov 2022
Reply
23 Aug 2022
REF. STANDARDS & IMPURITIES
Data currently not available.
Ask PharmaCompass should you need more information on this topic.